Donohue syndrome
WikiDoc Resources for Donohue syndrome |
Articles |
---|
Most recent articles on Donohue syndrome Most cited articles on Donohue syndrome |
Media |
Powerpoint slides on Donohue syndrome |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Donohue syndrome at Clinical Trials.gov Trial results on Donohue syndrome Clinical Trials on Donohue syndrome at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Donohue syndrome NICE Guidance on Donohue syndrome
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Donohue syndrome Discussion groups on Donohue syndrome Patient Handouts on Donohue syndrome Directions to Hospitals Treating Donohue syndrome Risk calculators and risk factors for Donohue syndrome
|
Healthcare Provider Resources |
Causes & Risk Factors for Donohue syndrome |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Donohue Syndrome (also known as Leprechaunism) is an extremely rare medical condition. It derives its name from the fact that those afflicted with the disease often have elfin features and are smaller than usual. Facial features indicative of Leprechaunism include protuberant and low-set ears, flaring nostrils, and thick lips. Physical features include enlarged breasts and clitorises in females and enlarged penises in males, as well as severe growth retardation. Sufferers are resistant to insulin. Early death is usual.
Leprechaunism is an autosomal recessive genetic disorder. The mutations responsible for Leprechaunism are found on the short arm chromosome 19 (19p13.2) within the coding sequence of the INSR gene (insulin receptor) causing the production of inactive receptor molecules.
Leprechaunism was first identified in 1948 by Dr. W.L. Donohue.
See also
References
External links
Template:Phakomatoses and other congenital malformations not elsewhere classified Template:WH Template:WS